Content area
Abstract
A series of benzopyrano[2,3-c]pyrazol-4(2H)-one derivatives were synthesized from readily available 1-phenyl- and 1-methyl-1H-pyrazol-3-ols by sequentially employing O-acylation, Fries rearrangement and potassium carbonate-induced cyclization. The anthelmintic properties of the obtained compounds were investigated in vivo in a model nematode, Caenorhabditis elegans. Five compounds, namely 2-phenyl[1]benzopyrano[2,3-c]pyrazol-4(2H)-one 33 and its 7-fluoro, 7-chloro-, 7-bromo- and 8-fluoro-analogues, 36, 38, 40 and 43, respectively, altered the development of C. elegans. While the activities of 33 and 43 were rather modest, compounds 36, 38 and 40 inhibited the growth of the worms at concentrations of approximately 1-3 µM. At these concentrations, the compounds did not kill the worms, but they strongly inhibited their development, with the majority of larvae never progressing past the L1 stage. Moreover, testing in non-cancer human cell lines showed that, with exception of 7-bromo derivative 40, the active compounds have favourable toxicity profiles.
Graphic abstract
Details
; Kadlecová Alena 2
; Žukauskaitė Asta 2
; Doležal Karel 3
; Strnad Miroslav 2
; Voller Jiří 2
; Eglė, Arbačiauskienė 1
; Holzer, Wolfgang 4
; Šačkus Algirdas 5
1 Kaunas University of Technology, Department of Organic Chemistry, Kaunas, Lithuania (GRID:grid.6901.e) (ISNI:0000 0001 1091 4533)
2 Palacký University, Laboratory of Growth Regulators, Institute of Experimental Botany, The Czech Academy of Science, Olomouc, Czech Republic (GRID:grid.10979.36) (ISNI:0000 0001 1245 3953)
3 Palacký University, Laboratory of Growth Regulators, Institute of Experimental Botany, The Czech Academy of Science, Olomouc, Czech Republic (GRID:grid.10979.36) (ISNI:0000 0001 1245 3953); Palacký University, Department of Chemical Biology and Genetics, Faculty of Science, Centre of the Region Haná for Biotechnological and Agricultural Research, Olomouc, Czech Republic (GRID:grid.10979.36) (ISNI:0000 0001 1245 3953)
4 University of Vienna, Division of Drug Synthesis, Department of Pharmaceutical Chemistry, Vienna, Austria (GRID:grid.10420.37) (ISNI:0000 0001 2286 1424)
5 Kaunas University of Technology, Institute of Synthetic Chemistry, Kaunas, Lithuania (GRID:grid.6901.e) (ISNI:0000 0001 1091 4533)





